Finding Capacity Alternatives in the Biopharmaceutical Industry — A Conversation with Kenna Harris of Scorpion Biological Services

At the most recent edition of the Biomanufacturing World Summit series recorded last November in San Diego we spoke with Kenna Harris, a vice president of Scorpion Biological Services, about how biopharmaceutical manufacturers are both finding and creating CMO and CDMO organizations to create additional capacity and where possible build alternatives to gather the inventory necessary to operate in a supply chain-constrained business environment.
--
Kenna Harris has spent over 19 years working in the contract research environment, with an emphasis on proteomics and oncology. She began her career as a program manager and spent five years leading a team to develop and characterize monoclonal and polyclonal antibodies. After this, she moved into business development with Taconic, specializing in the creation and breeding of GEM models.

Kenna later moved to Cell Signaling Technology as a proteomics specialist then subsequently to a similar role at SomaLogic. She then joined Mitra Biotech to help organizations create effective translational studies for oncology and developed a team at Concept Life Sciences specializing in the sale of chemistry and immunology services. Kenna is a graduate of UC Davis, with a BS in Biology, focusing on Neurobiology, Physiology and Behavior.

--
Scorpius BioManufacturing is an integrated contract research and contract development & manufacturing organization (CDMO) focused on rapidly advancing your mammalian and microbial biologic programs to the clinic and beyond. With end-to-end capabilities from discovery to limited-scale commercial production, we provide a broad array of R&D, analytical testing, and manufacturing services to pharmaceutical and biotech companies. With an experienced team and new, purpose-built, U.S. facilities, Scorpius is dedicated to easily accessible, transparent collaboration and flexible biologics biomanufacturing.

www.scorpiusbiologics.com.